| 000 | 01812 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250515012210.0 | ||
| 264 | 0 | _c20060307 | |
| 008 | 200603s 0 0 eng d | ||
| 022 | _a1399-543X | ||
| 024 | 7 |
_a10.1111/j.1399-543X.2005.00127.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPietropaolo, Massimo | |
| 245 | 0 | 0 |
_aCytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies. _h[electronic resource] |
| 260 |
_bPediatric diabetes _cDec 2005 |
||
| 300 |
_a184-92 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAutoantibodies _xblood |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xepidemiology |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFamily |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlutamate Decarboxylase _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aIslets of Langerhans _ximmunology |
| 650 | 0 | 4 |
_aIsoenzymes _ximmunology |
| 650 | 0 | 4 | _aLongitudinal Studies |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRisk Assessment |
| 700 | 1 | _aYu, Shui | |
| 700 | 1 | _aLibman, Ingrid M | |
| 700 | 1 | _aPietropaolo, Susan L | |
| 700 | 1 | _aRiley, Karen | |
| 700 | 1 | _aLaPorte, Ronald E | |
| 700 | 1 | _aDrash, Allan L | |
| 700 | 1 | _aMazumdar, Sati | |
| 700 | 1 | _aTrucco, Massimo | |
| 700 | 1 | _aBecker, Dorothy J | |
| 773 | 0 |
_tPediatric diabetes _gvol. 6 _gno. 4 _gp. 184-92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1399-543X.2005.00127.x _zAvailable from publisher's website |
| 999 |
_c16008416 _d16008416 |
||